Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.670
-0.020 (-1.18%)
Feb 4, 2026, 4:00 PM EST - Market closed
Inovio Pharmaceuticals Employees
Inovio Pharmaceuticals had 134 employees as of December 31, 2024. The number of employees increased by 12 or 9.84% compared to the previous year.
Employees
134
Change
12
Growth
9.84%
Revenue / Employee
$1,361
Profits / Employee
-$806,660
Market Cap
114.73M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 134 | 12 | 9.84% |
| Sep 30, 2024 | 127 | -8 | -5.93% |
| Jun 30, 2024 | 127 | -8 | -5.93% |
| Mar 31, 2024 | 122 | -62 | -33.70% |
| Dec 31, 2023 | 122 | -62 | -33.70% |
| Jun 30, 2023 | 135 | - | - |
| Dec 31, 2022 | 184 | -133 | -41.96% |
| Dec 31, 2021 | 317 | 55 | 20.99% |
| Dec 31, 2020 | 262 | 72 | 37.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 341 |
| Karyopharm Therapeutics | 279 |
| Korro Bio | 87 |
| Verrica Pharmaceuticals | 71 |
| Vivani Medical | 37 |
| Cardiff Oncology | 33 |
| Spero Therapeutics | 32 |
| Genelux | 24 |
INO News
- 25 days ago - Inovio Pharmaceuticals: Speculative Buy Thesis Hinges On INO-3107 - Seeking Alpha
- 5 weeks ago - FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP) - PRNewsWire
- 6 weeks ago - INOVIO Reports Inducement Grant Under Inducement Plan - PRNewsWire
- 2 months ago - Inovio Pharmaceuticals, Inc. (INO) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - INOVIO to Participate in December Investor Conferences - PRNewsWire
- 3 months ago - Inovio 3Q25 Review: EPS Miss, $25M Offering, And INO-3107 Progress - Seeking Alpha
- 3 months ago - INOVIO Announces Pricing of $25 Million Public Offering - PRNewsWire
- 3 months ago - Inovio Pharmaceuticals, Inc. (INO) Q3 2025 Earnings Call Transcript - Seeking Alpha